Effect of person-centred care on antipsychotic drug use in nursing homes (EPCentCare): a cluster-randomised controlled trial

Age and Ageing
Christin RichterSteffen Fleischer

Abstract

antipsychotic drugs are regularly prescribed as first-line treatment for neuropsychiatric symptoms in persons with dementia although guidelines clearly prioritise non-pharmacological interventions. we investigated a person-centred care approach, which has been successfully evaluated in nursing homes in the UK, and adapted it to German conditions. a 2-armed 12-month cluster-randomised controlled trial. nursing homes in East, North and West Germany. all prescribing physicians from both study arms received medication reviews for individual patients and were offered access to 2 h of continuing medical education. Nursing homes in the intervention group received educational interventions on person-centred care and a continuous supervision programme. Primary outcome: proportion of residents receiving at least one antipsychotic prescription after 12 months of follow-up. Secondary outcomes: quality of life, agitated behaviour, falls and fall-related medical attention, a health economics evaluation and a process evaluation. the study was conducted in 37 nursing homes with n = 1,153 residents (intervention group: n = 493; control group: n = 660). The proportion of residents with at least one antipsychotic medication changed after 12 month...Continue Reading

References

May 1, 1989·Journal of Gerontology·J Cohen-MansfieldA S Rosenthal
Mar 2, 1999·American Journal of Respiratory and Critical Care Medicine·F GallefossP K Rsgaard
Oct 20, 2001·Ageing and Society·Murna Downs
Mar 4, 2005·BMC Medical Research Methodology·Seokyung HahnJudith Watson
Apr 21, 2010·European Journal of Clinical Pharmacology·Kathrine F VandraasLars Slørdal
Sep 10, 2010·Deutsches Ärzteblatt International·Stefanie HoltPetra A Thürmann
May 24, 2012·JAMA : the Journal of the American Medical Association·Sascha KöpkeGabriele Meyer
Dec 14, 2012·The Cochrane Database of Systematic Reviews·Tanja RichterSascha Köpke
Feb 24, 2015·Journal of the American Medical Directors Association·Angela M SanfordBruno Vellas
Mar 21, 2015·BMJ : British Medical Journal·Graham F MooreJanis Baird
Jul 30, 2016·International Psychogeriatrics·Sarah I M JanusSytse U Zuidema
Feb 18, 2017·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Julia KirkhamDallas Seitz
Mar 4, 2017·Clinical Interventions in Aging·Sun Kyung Kim, Myonghwa Park
Feb 27, 2018·Journal of the American Medical Directors Association·Elizabeth G Birkenhäger-GillesseSytse U Zuidema
Aug 14, 2018·Journal of the American Medical Directors Association·Ellen Van LeeuwenThierry Christiaens

❮ Previous
Next ❯

Citations

Aug 31, 2020·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Claudia KirschHannah Haumann
Mar 23, 2021·European Geriatric Medicine·Anne SpinewineCarmel Hughes
Jun 2, 2021·Expert Opinion on Drug Safety·Elizabeth ManiasNarelle Borrott

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here